Compare Charles Schwab Corporation Common Stock (SCHW) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles Schwab Corporation Common Stock vs Zoetis Inc — how do they compare? Charles Schwab Corporation Common Stock trades at $100.2 (market cap $178.33B), while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 5.6× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| SCHW | ZTS | |
|---|---|---|
Market Cap | $178.33B | $31.95B |
Sector | Financials | Health |
52-Week High | $107.21 | $156.76 |
52-Week Low | $85.35 | $71.91 |
Dividend Yield | 1.25% | 2.78% |
Enterprise Value | — | $39.24B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
